Literature DB >> 775531

Evaluation of myocardial infarction with enzymatic indices.

G Ahumada, R Roberts, B E Sobel.   

Abstract

The severity of myocardial damage appears to be a common denominator contributing to electrophysiologic derangements, impaired ventricular function, and prognosis after myocardial infarction. Physiologically based models of processes affecting appearance and disappearance of CPK from the circulation may improve predictions and estimates of infarct size. Elevation of serum MB CPK isoenzyme activity appears to be a highly sensitive and specific indicator of myocardial injury. Despite the limitations discussed, recently developed enzymatic methods for detection, projection, and quantification of infarct dize have demonstrated that the extent of myocardial injury may be limited in selected patients by appropriate therapeutic measures. Further investigation may help to define the intervals between the onset of infarction and implementation of therapeutic maneuvers during which myocardial protection is possible, and may help to identify and differentiate inter ventions which salvage myocardium, those which improve cardiac performance without altering infarct size, and those which augment cardiac injury despite improving hemodynamics. Thus, in conjunction with electrophysiologic, radioisotopic, and hemodynamic techniques, enzymatic estimates and projection of infarct size should facilitate increased understanding of factors influencing the evolution of infarction and hasten development of effective therapeutic interventions designed to reduce myocardial damage.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 775531     DOI: 10.1016/0033-0620(76)90004-9

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  7 in total

1.  Serum creatine kinase activity following repeated bouts of isometric exercise with different muscle groups.

Authors:  J E Graves; P M Clarkson; P Litchfield; J P Kirwan; J P Norton
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1987

Review 2.  Creatine phosphokinase-MB (CPK-MB) and the diagnosis of myocardial infarction.

Authors:  P M Guzy
Journal:  West J Med       Date:  1977-12

3.  Left ventricular systolic time intervals in patients with acute myocardial infarction.

Authors:  B J Northover
Journal:  Br Heart J       Date:  1980-05

4.  Enzymatic diagnosis of infarction.

Authors:  B E Sobel
Journal:  West J Med       Date:  1977-12

5.  The influence of molsidomine on infarct size: an acute post-infarction pilot study with 303 patients.

Authors:  P Beaufils; H Kolsky; R Haiat; A Castaigne; R Slama
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

6.  Nifedipine limits infarct size for 24 hours in closed chest coronary embolized dogs.

Authors:  S Yoshida; J M Downey; F R Friedman; D E Chambers; D J Hearse; D M Yellon
Journal:  Basic Res Cardiol       Date:  1985 Jan-Feb       Impact factor: 17.165

7.  Serum interferon-gamma-inducible protein 10 level was increased in myocardial infarction patients, and negatively correlated with infarct size.

Authors:  Kazuya Koten; Satoshi Hirohata; Toru Miyoshi; Hiroko Ogawa; Shinichi Usui; Ryoko Shinohata; Mutsumi Iwamoto; Tomoki Kitawaki; Shozo Kusachi; Kosaku Sakaguchi; Tohru Ohe
Journal:  Clin Biochem       Date:  2007-10-11       Impact factor: 3.281

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.